0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Detection Methods Human Health Effects Nanoplastics Policy & Risk Remediation Sign in to save

Regulatory landscape of nanotechnology and nanoplastics from a global perspective

Regulatory Toxicology and Pharmacology 2021 368 citations ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 65 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Allan Jacqueline, Susanne Belz, Arnd Hoeveler, Marta Hugas, Haruhiro Okuda, Anil K. Patri, Hubert Rauscher, Primal Silva, William Slikker, Sokull-Kluettgen Birgit, Weida Tong, Elke Anklam

Summary

This review examines the global regulatory landscape for nanotechnology and nanoplastics, noting that regulations have not kept pace with the rapid growth of nanomaterials in consumer products. There is no globally agreed-upon definition of nanoplastics, and safety testing guidelines are still catching up. As research increasingly links nanoplastics to health concerns, the lack of coordinated regulation means people may be exposed to materials whose risks are not yet fully understood.

Nanotechnology and more particularly nanotechnology-based products and materials have provided a huge potential for novel solutions to many of the current challenges society is facing. However, nanotechnology is also an area of product innovation that is sometimes developing faster than regulatory frameworks. This is due to the high complexity of some nanomaterials, the lack of a globally harmonised regulatory definition and the different scopes of regulation at a global level. Research organisations and regulatory bodies have spent many efforts in the last two decades to cope with these challenges. Although there has been a significant advancement related to analytical approaches for labelling purposes as well as to the development of suitable test guidelines for nanomaterials and their safety assessment, there is a still a need for greater global collaboration and consensus in the regulatory field. Furthermore, with growing societal concerns on plastic litter and tiny debris produced by degradation of littered plastic objects, the impact of micro- and nanoplastics on humans and the environment is an emerging issue. Despite increasing research and initial regulatory discussions on micro- and nanoplastics, there are still knowledge gaps and thus an urgent need for action. As nanoplastics can be classified as a specific type of incidental nanomaterials, current and future scientific investigations should take into account the existing profound knowledge on nanotechnology/nanomaterials when discussing issues around nanoplastics. This review was conceived at the 2019 Global Summit on Regulatory Sciences that took place in Stresa, Italy, on 24-26 September 2019 (GSRS 2019) and which was co-organised by the Global Coalition for Regulatory Science Research (GCRSR) and the European Commission's (EC) Joint Research Centre (JRC). The GCRSR consists of regulatory bodies from various countries around the globe including EU bodies. The 2019 Global Summit provided an excellent platform to exchange the latest information on activities carried out by regulatory bodies with a focus on the application of nanotechnology in the agriculture/food sector, on nanoplastics and on nanomedicines, including taking stock and promoting further collaboration. Recently, the topic of micro- and nanoplastics has become a new focus of the GCRSR. Besides discussing the challenges and needs, some future directions on how new tools and methodologies can improve the regulatory science were elaborated by summarising a significant portion of discussions during the summit. It has been revealed that there are still some uncertainties and knowledge gaps with regard to physicochemical properties, environmental behaviour and toxicological effects, especially as testing described in the dossiers is often done early in the product development process, and the material in the final product may behave differently. The harmonisation of methodologies for quantification and risk assessment of nanomaterials and micro/nanoplastics, the documentation of regulatory science studies and the need for sharing databases were highlighted as important aspects to look at.

Sign in to start a discussion.

More Papers Like This

Article Tier 2

Safe nanomaterials: from their use, application, and disposal to regulations

This review surveys the global applications of nanomaterials across medicine, food, textiles, and electronics, along with the health and environmental risks they pose. It highlights that regulations governing nanomaterial safety vary widely between countries and calls for global standards based on a precautionary principle to ensure their responsible use and disposal.

Article Tier 2

Can Current Regulations Account for Intentionally Produced Nanoplastics?

This study examines whether current regulatory frameworks adequately address intentionally produced nanoplastics, highlighting gaps in existing policies for managing these engineered materials.

Article Tier 2

Studying the environmental impact of nanoplastics: Strategies and limitations

This commentary highlights the challenges of studying nanoplastics in the environment, noting that research is still in early stages and hampered by inconsistent definitions, limited standardized tests, and difficulties extrapolating lab findings to real-world conditions. Developing robust, standardized methods is critical before we can accurately assess how nanoplastics affect ecosystems and human health at scale.

Article Tier 2

Micro- and nanoplastics: a global threat to health and the environment

This global review assesses the evidence for micro- and nanoplastics as threats to both environmental and human health, covering contamination of air, food, and water, and discussing the challenges of risk assessment given incomplete toxicological data.

Article Tier 2

Regulatory Science Perspective on the Analysis of Microplastics and Nanoplastics in Human Food

This paper from a regulatory science perspective highlights that current methods for detecting and measuring microplastics and nanoplastics in food are not yet reliable enough for formal food safety assessments. There is a lack of standardized definitions, reference materials, and validated analytical methods, especially for nanoplastics. Until these gaps are addressed, it will be difficult for food safety agencies to accurately determine how much plastic contamination people are consuming and whether it poses a health risk.

Share this paper